Celgene's Chopra joins e-Therapeutics board
This article was originally published in Scrip
Biotech company e-Therapeutics has appointed Dr Rajesh Chopra to its board as a non-executive director. Since 2009, Dr Chopra has been vice-president of translational and early drug development at Celgene. Prior to this current role, he spent five years at AstraZeneca in a number of positions including medical science director.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.